CVS Stock Recent News

CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News reported on Monday, citing people familiar with the matter.

The Trump administration said it will raise Medicare Advantage payments sharply, good news for Humana, UnitedHealth and other health insurers. The post Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike appeared first on Investor's Business Daily.

CVS Health's strong track record of stable cash generation aids it amid the broader market sell-offs due to escalating 2025 Trump tariffs.

CVS has been worst hit by the rising healthcare utilization/ medical costs, as observed in the relatively higher medical benefit ratio in FQ4'24/ FY2024 compared to its peers. Even so, we believe that FY2024 (and maybe FY2025) are likely to be its trough years, as the management offers promising guidance and the consensus raises forward estimates. Despite industry-wide issues, CVS remains well positioned to weather through the near-term uncertainties, thanks to the pricing increases and the stable balance sheet health.

I rate CVS Health as a BUY due to its undervaluation and potential for financial growth despite current sector uncertainties. CVS's revenue is growing, but profitability is declining due to retail competition and PBMs shrinking reimbursement rates. CVS's PBM business, Caremark, holds a significant market share, positioning it better than competitors like Walgreens.

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The stock market remains in freefall, today on fears of a full-blown trade war having been ignited, sending the stock market officially into correction turf.

As the first quarter of 2025 wrapped up, the initial wave of optimism that carried markets into the new year had largely faded. Stocks opened strong, fueled by momentum from the late 2024 post-election rally, but the broader market lost ground as trade war fears and economic uncertainty weighed heavily on sentiment.

WOONSOCKET, R.I. , April 3, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Thursday, May 1 st, 2025, at 8:00 a.m.

In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day.